A highly selective and potent HPK1 inhibitor enhances immune cell activation and induces robust tumor growth inhibition in a murine syngeneic tumor model

被引：0
|
作者：
Ciccone, D. [1 ]
Lazari, V. [2 ]
Linney, I. [2 ]
Briggs, M. [2 ]
Carreiro, S. [1 ]
Waddell, I. [2 ]
Hill, C. [2 ]
Loh, C. [1 ]
Tummino, P. [1 ]
Collis, A. [1 ]
Kaila, N. [1 ]
机构：
[1] Nimbus Therapeut, Res & Dev, Cambridge, MA USA
[2] Charles River Labs, Res, Chesterford Pk, England
来源：
EUROPEAN JOURNAL OF CANCER | 2020年 / 138卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
46
引用
收藏
页码：S20 / S20
页数：1
相关论文
共 50 条
  • [41] SUPPRESSION OF TUMOR GROWTH AND INTERRUPTION OF TUMOR ANGIOGENESIS BY SELECTIVE INHIBITION OF EITHER TNFR1/P55 OR TNFR2/75 IN MURINE MODEL OF LUNG CARCINOMA
    Sasi, S.
    Gilbert, H-Y
    Silver, M.
    Coleman, C.
    Kunder, S.
    Curry, C.
    Hlatky, L.
    Qin, G.
    Kishore, R.
    Goukassian, D. A.
    ADVANCES IN TNF FAMILY RESEARCH, 2011, 691 : 749 - 750
  • [42] GSK-3 inhibitor elraglusib (9-ING-41) to enhance tumor-infiltrating immune cell activation in tumor biopsies and synergize with anti-PD-L1 in a murine model of colorectal cancer
    El-Deiry, Wafik S.
    Huntington, Kelsey
    Louie, Anna
    Srinivasan, Praveen
    Schorl, Cristoph
    Lu, Shaolei
    Silverberg, David
    Newhouse, Daniel
    Wu, Zhijin
    Zhou, Lanlan
    Ryspayeva, Dinara
    Borden, Brittany
    Giles, Francis J.
    Dooner, Mark
    Carneiro, Benedito A.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [43] Selective inhibition of mutant KRAS cell and tumor growth by PHT-7.3, an inhibitor of the KRas signaling nanocluster protein Cnk1
    Delaney, Roisin
    Maruggi, Marco
    Indarte, Martin
    Lemos, Robert
    Grandjean, Geoff
    Kirkpatrick, Lynn
    Powis, Garth
    CANCER RESEARCH, 2017, 77
  • [44] Combined Radiation and PI3Kgd Inhibitor Enhances Anti-Tumor Effect of PD-1 Blockade in Immune-competent Syngeneic Breast Cancer Model
    Han, M. G.
    Jang, B. S.
    Kang, M. H.
    Chang, W. I.
    Kim, I. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S109 - S110
  • [45] HMPL-453, a highly selective inhibitor of fibroblast growth factor receptors 1, 2, and 3, displays potent activity in FGFR-altered tumor models
    Hu, Jia
    Ni, Jun
    Jiao, Longxian
    Zhou, Jinghong
    Fan, Shiming
    Tang, Renxiang
    Zhang, Wei
    Ge, Xuelei
    Zhang, Qihang
    Yu, Juntao
    Yu, Ying
    Shi, Dongxia
    Cheng, Min
    Xue, Weifang
    Xia, Sumei
    Zhong, Zeyu
    Wang, Jian
    Sai, Yang
    Qing, Weiguo
    Dai, Guangxiu
    Ren, Yongxin
    Shi, Michael
    Su, Weiguo
    CANCER RESEARCH, 2023, 83 (07)
  • [46] The LSD1 Specific Inhibitor INCB059872 enhances the activity of immune checkpoint blockade by reshaping the myeloid compartment in the syngeneic 4T1 mouse mammary tumor model
    Condamine, Thomas
    Wang, Steve
    Diamond, Melody
    Hall, Leslie
    Liu, Huiqing
    Chadderton, Antony
    Lu, Jin
    He, Chunhong
    Wu, Liangxing
    Burn, Timothy
    Yao, Wenqing
    Hollis, Gregory
    Huber, Reid
    Ruggeri, Bruce
    Scherle, Peggy
    Koblish, Holly
    Lee, Sang Hyun
    CANCER RESEARCH, 2017, 77
  • [47] YF550-C1, an E3 ligase inhibitor of CBL-B, to demonstrate T cell and NK cell activation and anti-tumor activities in syngeneic and PDX tumor model.
    Ye, Jie
    Liu, Tengfei
    Liu, Yahui
    Liu, Xueqiang
    Wu, Fan
    Lu, Tingting
    An, Na
    Chai, Yushuang
    Lin, Xingyu
    Liao, Xuebin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [48] Inhibition of tumor growth by targeting the MDA5-IPS-1 pathway requires coordinated induction of cancer cell death and immune activation
    Yu, Xiaofei
    Fisher, Paul
    Wang, Xiang-Yang
    JOURNAL OF IMMUNOLOGY, 2014, 192
  • [49] OMX-0407, a highly potent SIK3 inhibitor, sensitizes tumor cells to cell death and eradicates tumors in combination with PD-1 inhibition
    Hartl, Christina
    Maser, Ilona-Petra
    Michels, Tillmann
    Milde, Ronny
    Klein, Vanessa
    Beckhove, Philipp
    Khandelwal, Nisit
    Loferer, Hannes
    Bissinger, Stefan
    CANCER RESEARCH, 2022, 82 (12)
  • [50] AKT1 Activation is Obligatory for Spontaneous BCC Tumor Growth in a Murine Model that Mimics Some Features of Basal Cell Nevus Syndrome
    Kim, Arianna L.
    Back, Jung Ho
    Zhu, Yucui
    Tang, Xiuwei
    Yardley, Nathan P.
    Kim, Katherine J.
    Athar, Mohammad
    Bickers, David R.
    CANCER PREVENTION RESEARCH, 2016, 9 (10) : 794 - 802
12345